Year All202420232022202120202019201820172016201520142013201220112009 Feb 07, 2024 REGENXBIO Announces Completion of Enrollment in Cohort 2 and Additional Positive Interim Data in AFFINITY DUCHENNE® Trial Jan 31, 2024 REGENXBIO Announces Presentations at the 20th Annual WORLDSymposium 2024 Jan 16, 2024 REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery Jan 10, 2024 REGENXBIO Announces Presentation at the Hawaiian Eye and Retina 2024 Meeting Jan 08, 2024 U.S. District Court Issues Decision on REGENXBIO and University of Pennsylvania NAV® Technology Patent Infringement Lawsuit
Feb 07, 2024 REGENXBIO Announces Completion of Enrollment in Cohort 2 and Additional Positive Interim Data in AFFINITY DUCHENNE® Trial
Jan 16, 2024 REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery
Jan 08, 2024 U.S. District Court Issues Decision on REGENXBIO and University of Pennsylvania NAV® Technology Patent Infringement Lawsuit